908 Devices Inc. (MASS) Financial Analysis & Valuation | Quarter Chart
908 Devices Inc. (MASS)
MASSPrice: $6.99
Fair Value: 🔒
🔒score
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company... more
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and... more
Description
Shares
| Market Cap | $252.99M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Kevin J. Knopp |
| IPO Date | 2020-12-18 | CAGR | 0.18% |
| Employees | 246 | Website | www.908devices.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
MASS chart loading...
Fundamentals
Technicals
| Enterprise Value | $295.72M | P/E Ratio | -3.38 |
| Forward P/E | -24.2 | PEG Ratio | — |
| P/S Ratio | 7.1 | P/B Ratio | 2.87 |
| P/CF Ratio | -15.22 | P/FCF Ratio | -14.5 |
| EPS | $-2.07 | EPS Growth 1Y | -93.22% |
| EPS Growth 3Y | -85.88% | EPS Growth 5Y | -53.86% |
| Revenue Growth 1Y | 4.49% | Gross Margin | 0.49% |
| Operating Margin | -1.09% | Profit Margin | -0.07% |
| ROE | -0.03% | ROA | -0.02% |
| ROCE | -0.42% | Current Ratio | 3.49 |
| Quick Ratio | 3.12 | Cash Ratio | 1.51 |
| Debt/Equity | 0.03 | Interest Coverage | — |
| Altman Z Score | 1.35 | Piotroski Score | 2 |